Journal article

The potential benefit of stem cell therapy after stroke: an update.

Soma Banerjee, Deborah A Williamson, Nagy Habib, Jeremy Chataway

Vasc Health Risk Manag | Published : 2012

Abstract

Stroke is a leading cause of death and disability worldwide. Stem cell therapy is an emerging therapeutic modality with evidence of significant benefits in preclinical stroke models. A number of phase I and II clinical trials have now been completed, with several more currently under way. Translation to the bedside, however, remains a long way off, and there are many questions that remain unanswered. This review will summarize the current evidence and ongoing clinical trials worldwide, and explore the challenges to making this a realistic treatment option for the future.